US FDA ends Monsanto Vistive soybeans review
The US Food and Drug Administration (FDA) has completed its food safety consultation process for Monsanto’s genetically modified MON87705 soybeans. The line will be marketed under the Vistive Gold brand. The beans produce a high-oleic, low-saturate, low-trans fat oil. The conclusion of the FDA consultation completes one of the key regulatory steps to allow for full commercial introduction of Vistive Gold soybeans, Monsanto points out. The company plans to offer the MON87705 trait in combination with its Genuity Roundup Ready 2 Yield line (MON89788).